|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-09-23 EDT
|
5-day change | 1st Jan Change | ||
| 8.830 SEK | -0.67% |
|
-7.35% | -34.59% |
| 09-17 | Vivesto sees tumor effect with Paccal Vet in cat study | FW |
| 09-17 | Vivesto reports positive topline results from the Paccal Vet feline study | FW |
Chart: Technical Analysis
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| VIVE | Delayed | |
Deutsche Boerse AG
| OMA | Delayed | |
CBOE
| 0N4A | Real-time | |
CBOE
| OASMs | Real-time | |
Börse Stuttgart
| OMA | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 9.53 | 17 | 23.25 |
| Spread/Res. | -7.35% | -48.06% | -62.02% |
| Spread/Supp. | +1.38% | +16.03% | +14.08% |
| Support | 8.71 | 7.61 | 7.74 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- VIVE Stock
- Charts Vivesto AB
Select your edition
All financial news and data tailored to specific country editions

















